Clinical Trial Update: Study of Irinotecan,Oxaliplatin, and S1 in Patients With Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating irinotecan, oxaliplatin, and S1 in patients with advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)
• S1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Qingdao Central Hospital | Conditions: Overall Survival | Phase 2 | Status: COMPLETED